ABBV
- NYSE - Medical-Ethical Drugs
AbbVie Inc
|
$163.90 |
-2.65 -1.59%
|
$166.28
|
$175.91
|
-6.83% |
3,535,950 66.68%
|
5,303,000
|
Most Recent Note for ABBV - 1/9/2023 12:11:51 PM
Reported earnings +29% on +3% sales revenues for the Sep '22 quarter versus the year ago period. Sub par sales revenues growth and prior quarterly earnings history is not a match with the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ACLS
- NASDAQ - ELECTRONICS - Semiconductor Equipment & Mate
Axcelis Technologies Inc
|
$93.32 |
+5.78
6.60%
|
$93.75
|
$88.81
|
5.08% |
377,152 101.11%
|
373,000
|
Most Recent Note for ACLS - 1/9/2023 12:13:43 PM
Powering to a new 52-week high with today's 4th consecutive volume-driven gain. Reported Sep '22 quarterly earnings +49% on +30% sales revenues versus the year ago period, its 10th strong quarterly comparison. Up and down annual earnings (A criteria) history is not a great match with the fundamental guidelines of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AE
- AMEX - Oil&Gas-Refining/Mktg
Adams Res & Energy Inc
|
$40.38 |
+1.73
4.49%
|
$41.00
|
$41.82
|
-3.46% |
21,456 107.28%
|
20,000
|
Most Recent Note for AE - 1/9/2023 12:15:44 PM
Fundamentals remain a concern. This thinly-traded AMEX listed stock has an erratic quarterly and annual earnings history (C and A criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ARHS
- NASDAQ - RETAIL - Home Furnishing Stores
Arhaus Inc
|
$11.24 |
+1.00
9.76%
|
$12.23
|
$12.98
|
-13.41% |
1,081,625 214.18%
|
505,000
|
Most Recent Note for ARHS - 1/9/2023 12:21:27 PM
Gapped up today. Three of the past 4 quarterly comparisons through Sep '22 were above the +25% minimum earnings guideline (C criteria). Limited history remains a concerns since its $13 IPO on 11/04/21.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AZN
- NYSE - DRUGS - Drug Manufacturers - Major
Astrazeneca Plc Ads
|
$71.29 |
+0.49
0.69%
|
$71.66
|
$71.70
|
-0.57% |
3,568,547 76.09%
|
4,690,000
|
Most Recent Note for AZN - 1/9/2023 12:36:28 PM
Today's 5th consecutive gain is challenging its 52-week high after a deep consolidation. Noted in prior mid-day reports - "Reported Sep '22 quarterly earnings +68% on +11% sales revenues versus the year ago period. Prior quarterly and annual earnings history is not a great match with the fundamental guidelines of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BBSI
- NASDAQ - DIVERSIFIED SERVICES - Staffing & Outsourcing Service
Barrett Business Svcs
|
$93.77 |
-0.54 -0.57%
|
$94.50
|
$100.79
|
-6.97% |
37,677 76.89%
|
49,000
|
Most Recent Note for BBSI - 1/9/2023 1:15:50 PM
Consolidating near its 50 DMA line ($94.13). Noted in prior mid-day reports - "Reported Sep '22 quarterly earnings +25% on +11% sales revenues versus the year ago period but fundamental concerns remain. Prior quarterly and annual earnings (C and A criteria) history has not been strong and steady."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CASS
- NASDAQ - BANKING - Regional - Southwest Banks
Cass Information System
|
$48.68 |
+0.54
1.12%
|
$49.50
|
$48.94
|
-0.53% |
38,107 92.94%
|
41,000
|
Most Recent Note for CASS - 1/9/2023 1:16:57 PM
St Louis, MO-based payment processing firm is rallying above its 2021 high with today's 4th consecutive volume-driven gain after a long and deep consolidation. Three of the past 4 quarterly earnings comparisons through Sep '22 were above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been sub par.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CNHI
- NYSE - Machinery-Constr/Mining
C N H Industrial Nv
|
$16.88 |
+0.16
0.93%
|
$17.06
|
$17.00
|
-0.74% |
2,869,720 69.99%
|
4,100,000
|
Most Recent Note for CNHI - 1/9/2023 1:20:20 PM
Perched within close striking distance of its 52-week high with today's 5th consecutive gain. Prior mid-day reports cautioned members - "Reported Sep '22 quarterly earnings +21% on +24% sales revenues versus the year ago period. Big downturn in FY '20 annual earnings (A criteria) is a flaw with regard to the strict fundamental guidelines of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ELF
- NYSE - Cosmetics/Personal Care
E L F Beauty Inc
|
$58.02 |
-0.04 -0.06%
|
$58.49
|
$58.76
|
-1.27% |
809,806 118.91%
|
681,000
|
Most Recent Note for ELF - 1/9/2023 1:22:07 PM
On the prior session it hit a new 52-week high with a volume-driven gain after consolidating for the past 5 weeks above its 50 DMA line ($52.90). Reported strong Mar, Jun, and Sep '21 quarterly results above the +25% minimum earnings guideline (C criteria). Fundamental concerns remain as a downturn in its FY '19 and '20 annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HGBL
- NASDAQ - Finance-Investment Mgmt
Heritage Global Inc
|
$2.53 |
-0.13 -4.89%
|
$2.75
|
$2.86
|
-11.54% |
78,117 88.77%
|
88,000
|
Most Recent Note for HGBL - 1/9/2023 1:26:19 PM
Thinly-traded Finance - Investment Management firm is perched near its 52-week high after recently finding support at its 50 DMA line ($2.31). Reported Sep '22 quarterly earnings +500% on +111% sales revenues versus the year ago period, its 2nd strong quarterly comparison. Prior quarterly and annual earnings (C and A criteria) history has not been a match with the fact-based investment system's guidelines, and low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LUNA
- NASDAQ - Medical-Research Eqp/Svc
Luna Innovations Inc
|
$10.03 |
+0.27
2.77%
|
$10.15
|
$10.45
|
-4.02% |
152,096 89.47%
|
170,000
|
Most Recent Note for LUNA - 1/9/2023 1:27:37 PM
Following volume-driven gains it has held its ground. Prior mid-day reports cautioned members - "Went through a deep consolidation since dropped from the Featured Stocks list on 8/19/21. Reported Sep '22 quarterly earnings +200% on +43% sales revenues versus the year ago period. Prior quarterly and annual earnings history is not a match with the fundamental guidelines of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LYTS
- NASDAQ - Bldg-Constr Prds/Misc
L S I Industries Inc
|
$12.82 |
+0.28
2.23%
|
$13.20
|
$12.82
|
0.00% |
226,363 141.48%
|
160,000
|
Most Recent Note for LYTS - 1/9/2023 1:28:53 PM
Perched at its 52-week high with today's 3rd consecutive volume-driven gain. Rallied abruptly from a low of $6.55 on 10/25/22. It has not formed a sound looking base. Recent quarterly comparisons through Sep '22 versus the year ago period showed strong sales revenues and earnings increases versus the year ago periods. Annual earnings history has been strong after a downturn in FY '19.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MBLY
- NYSE - Elec-Semicondctor Fablss
Mobileye Global Inc
|
$33.99 |
+2.37
7.50%
|
$34.25
|
$37.31
|
-8.90% |
2,608,765 103.40%
|
2,523,000
|
Most Recent Note for MBLY - 1/9/2023 1:32:54 PM
Israel-based fabless Semiconductor firm completed its $21 IPO on 10/26/22. Reported earnings +8% on +38% sales revenues for the Sep '22 quarter versus the year ago period. Prior quarterly earnings increases were not strong and steady above the +25% minimum guideline (C criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MCFT
- NASDAQ - Leisure-Products
Mastercraft Boat Holdings Inc
|
$27.82 |
+0.86
3.19%
|
$27.98
|
$29.69
|
-6.30% |
96,142 106.82%
|
90,000
|
Most Recent Note for MCFT - 1/9/2023 1:35:03 PM
The 2 latest quarterly earnings comparisons through Sep '22 were well above the +25% minimum earnings guideline (C criteria) but fundamental concerns remain. Annual earnings had a downturn in FY '20. Went through a long consolidation since noted with caution at multi-year highs in the 5/14/21 mid-day report. Completed a Secondary Offering on 12/08/16. Completed its $10 IPO on 7/17/15.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MMX
- AMEX - Mining-Gold/Silver/Gems
Maverik Metals Inc
|
$4.76 |
+0.00
0.00%
|
$4.83
|
$5.45
|
-12.66% |
303,979 94.40%
|
322,000
|
Most Recent Note for MMX - 1/9/2023 1:35:14 PM
Quarterly comparisons through Sep '22 showed earnings increases below the +25% minimum guideline (C criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MNSO
- NYSE - RETAIL - Discount, Variety Stores
Miniso Group Hldg Cl A
|
$13.06 |
+0.55
4.36%
|
$13.34
|
$13.00
|
0.42% |
807,320 92.80%
|
870,000
|
Most Recent Note for MNSO - 1/9/2023 1:35:50 PM
Prior mid-day reports noted - "Quarterly and annual earnings history has not been strong and steady while sales revenues have been waning. Faces resistance due to overhead supply up to the $35 level."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MTRN
- NYSE - METALS & MINING - Industrial Metals & Minerals
Materion Corp
|
$93.54 |
+2.62
2.88%
|
$93.54
|
$97.89
|
-4.45% |
90,519 65.12%
|
139,000
|
Most Recent Note for MTRN - 1/9/2023 1:37:20 PM
Rebounding toward its all-time high with today's 5th consecutive volume-driven gain following a deep pullback. Reported earnings +8% on +10% sales revenues for the Sep '22 quarter versus the year ago period. Prior quarterly comparisons were well above the +25% minimum earnings guideline (C criteria). Its up and down annual earnings history (A criteria) leaves fundamental concerns.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NBIX
- NASDAQ - DRUGS - Biotechnology
Neurocrine Biosciences
|
$111.20 |
-11.83 -9.61%
|
$123.00
|
$129.29
|
-14.00% |
841,034 107.69%
|
781,000
|
Most Recent Note for NBIX - 1/9/2023 1:39:06 PM
Big volume-driven loss today violated its 50 DMA line ($120) triggering a technical sell signal. Last noted with caution in the 12/13/22 mid-day report - "Reported Sep '22 quarterly earnings +69% on +31% sales revenues versus the year ago period. Fundamental concerns remain due to sub par quarterly and annual earnings growth since dropped from the Featured Stocks list on 8/07/20."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NECB
- NASDAQ - Finance-Savings & Loan
Northeast Cmnty Bancorp
|
$15.13 |
-0.10 -0.62%
|
$15.33
|
$15.26
|
-0.88% |
45,055 72.67%
|
62,000
|
Most Recent Note for NECB - 1/9/2023 1:39:45 PM
Perched at its 52-week high today following 2 consecutive volume-driven gains. Reported Sep '22 quarterly earnings +880% on +56% sales revenues versus the year ago period, its 2nd strong quarterly comparison. Prior quarterly earnings increases through Mar '22 were below the +25% minimum guideline (C criteria) versus the year ago periods.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NOA
- NYSE - Oil&Gas-Field Services
North American Const Grp
|
$13.97 |
+0.54
4.02%
|
$13.99
|
$16.12
|
-13.34% |
33,148 94.71%
|
35,000
|
Most Recent Note for NOA - 1/9/2023 1:40:44 PM
Choppy consolidation continues while again rebounding above prior highs since finding support near its 50 DMA line. Reported stronger Sep '22 quarterly results but fundamental concerns remain.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
OR
- NYSE - Mining-Gold/Silver/Gems
Osisko Gold Royalties
|
$12.71 |
-0.02 -0.12%
|
$12.90
|
$14.57
|
-12.80% |
602,445 90.32%
|
667,000
|
Most Recent Note for OR - 1/9/2023 1:42:15 PM
Quarterly earnings comparisons through Sep '22 were well below the +25% minimum earnings guideline (C criteria) and fundamental concerns remain. Annual earnings had a downturn in FY '20.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PERI
- NASDAQ - Comml Svcs-Advertising
Perion Networks Ltd
|
$29.24 |
+0.43
1.49%
|
$29.59
|
$29.57
|
-1.12% |
352,045 87.36%
|
403,000
|
Most Recent Note for PERI - 1/9/2023 1:44:09 PM
Posted 3 consecutive volume-driven gains but still faces some resistance due to overhead supply up to the $33 level. Found support near its 50 DMA line since noted in the 12/06/22 mid-day report - "Reported Sep '22 quarterly earnings +53% on +31% sales revenues versus the year ago period. Prior quarterly earnings history (C criteria) has been above the +25% minimum. Annual earnings (A criteria) history has been improving steadily after a downturn from FY '15-18."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PRMW
- NASDAQ - Beverages-Non-Alcoholic
Primo Water Corp
|
$15.98 |
+0.11
0.66%
|
$16.40
|
$17.78
|
-10.15% |
590,562 70.56%
|
837,000
|
Most Recent Note for PRMW - 1/9/2023 1:45:05 PM
Last noted with caution in the 12/14/22 mid-day report - "Reported earnings +0% on +6% sales revenues for the Sep '22 quarter versus the year ago period. Quarterly and annual earnings (C and A criteria) history has been erratic and not a match with the fact-based investment system's fundamental guidelines. Completed a new Public Offering on 5/18/18."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SBR
- NYSE - FINANCIAL SERVICES - Diversified Investments
Sabine Royalty Tr Ubi
|
$85.01 |
+2.27
2.74%
|
$86.46
|
$90.73
|
-6.30% |
58,894 81.80%
|
72,000
|
Most Recent Note for SBR - 1/9/2023 1:46:12 PM
Rebounded above its 50 DMA line ($82.39) and on track today for a 3rd consecutive gain. Quarterly comparisons through Sep '22 have shown impressive sales revenues and earnings increases over the year ago periods. Annual earnings history (A criteria) has been up and down.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SMCI
- NASDAQ - COMPUTER HARDWARE - Networking &; Communication Dev
Super Micro Computer Inc
|
$88.92 |
+4.53
5.37%
|
$92.80
|
$95.22
|
-6.62% |
1,136,833 97.50%
|
1,166,000
|
Most Recent Note for SMCI - 1/9/2023 1:47:18 PM
Consolidating above its 50 DMA line ($83.11) and nearly challenged its 52-week high with today's early gain. Reported Sep '22 quarterly earnings +490% on +79% sales revenues versus the year ago period, its 4th strong quarterly earnings increase well above the +25% minimum guideline (C criteria). Its annual earnings history (A criteria) had a downturn in FY '21.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
WMK
- NYSE - RETAIL - Grocery Stores
Weis Markets Inc
|
$85.37 |
-0.58 -0.67%
|
$86.09
|
$95.57
|
-10.67% |
42,421 66.28%
|
64,000
|
Most Recent Note for WMK - 1/9/2023 1:48:08 PM
Meeting resistance near its 50 DMA line. Fundamental concerns remain.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
WWE
- NYSE - LEISURE - General Entertainment
World Wrestling Entmnt
|
$88.81 |
+4.54
5.38%
|
$89.06
|
$89.43
|
-0.70% |
1,453,810 189.54%
|
767,000
|
Most Recent Note for WWE - 1/9/2023 1:48:50 PM
On news Vince McMahon is returning it gapped up on the prior session for a considerable gain and new all time high. Recently tested support at its 200 DMA line ($68.54). Had a new CEO as of 6/17/22. Reported Sep '22 quarterly earnings +25% on +19% sales revenues versus the year ago period, its 4th consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Sequential quarterly comparisons show deceleration in its sales revenues and earnings growth rate. The prior 4 quarterly earnings comparisons were negative, down from the year ago periods. Annual earnings (A criteria) history had a downturn in FY '19.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|